FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017332009> ?p ?o ?g. }

• W2017332009 endingPage "412" @default.
• W2017332009 startingPage "406" @default.
• W2017332009 abstract "Interferon-β (IFN-β) is a mainstay therapy for multiple sclerosis. However, only two thirds of patients respond to therapy, and clinical symptoms worsen in some patients. Chandar Raman and his colleagues show that IFN-β alleviates disease induced by T helper type 1 cells and exacerbates disease induced by T helper type 17 cells in mice. They also show that these effects of IFN-β rely on IFN-γ signaling ( pages 376–377 ). Interferon-β (IFN-β) is the major treatment for multiple sclerosis. However, this treatment is not always effective. Here we have found congruence in outcome between responses to IFN-β in experimental autoimmune encephalomyelitis (EAE) and relapsing-remitting multiple sclerosis (RRMS). IFN-β was effective in reducing EAE symptoms induced by T helper type 1 (TH1) cells but exacerbated disease induced by TH17 cells. Effective treatment in TH1-induced EAE correlated with increased interleukin-10 (IL-10) production by splenocytes. In TH17-induced disease, the amount of IL-10 was unaltered by treatment, although, unexpectedly, IFN-β treatment still reduced IL-17 production without benefit. Both inhibition of IL-17 and induction of IL-10 depended on IFN-γ. In the absence of IFN-γ signaling, IFN-β therapy was ineffective in EAE. In RRMS patients, IFN-β nonresponders had higher IL-17F concentrations in serum compared to responders. Nonresponders had worse disease with more steroid usage and more relapses than did responders. Hence, IFN-β is proinflammatory in TH17-induced EAE. Moreover, a high IL-17F concentration in the serum of people with RRMS is associated with nonresponsiveness to therapy with IFN-β." @default.
• W2017332009 created "2016-06-24" @default.
• W2017332009 creator A5000641039 @default.
• W2017332009 creator A5013627205 @default.
• W2017332009 creator A5020603727 @default.
• W2017332009 creator A5021321096 @default.
• W2017332009 creator A5021775232 @default.
• W2017332009 creator A5031900866 @default.
• W2017332009 creator A5032730610 @default.
• W2017332009 creator A5037905104 @default.
• W2017332009 creator A5041768709 @default.
• W2017332009 creator A5044949501 @default.
• W2017332009 creator A5049519284 @default.
• W2017332009 creator A5056838229 @default.
• W2017332009 creator A5065640717 @default.
• W2017332009 creator A5074815989 @default.
• W2017332009 creator A5076669758 @default.
• W2017332009 creator A5078507054 @default.
• W2017332009 creator A5080425769 @default.
• W2017332009 creator A5083119149 @default.
• W2017332009 creator A5091865567 @default.
• W2017332009 date "2010-03-28" @default.
• W2017332009 modified "2023-10-13" @default.
• W2017332009 title "T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis" @default.
• W2017332009 cites W1489608758 @default.
• W2017332009 cites W1497205974 @default.
• W2017332009 cites W1567392757 @default.
• W2017332009 cites W1998895238 @default.
• W2017332009 cites W2002215582 @default.
• W2017332009 cites W2004660702 @default.
• W2017332009 cites W2006249161 @default.
• W2017332009 cites W2007536025 @default.
• W2017332009 cites W2011483479 @default.
• W2017332009 cites W2014750930 @default.
• W2017332009 cites W2016624604 @default.
• W2017332009 cites W2023389632 @default.
• W2017332009 cites W2046413321 @default.
• W2017332009 cites W2054304062 @default.
• W2017332009 cites W2058420050 @default.
• W2017332009 cites W2067640086 @default.
• W2017332009 cites W2078844752 @default.
• W2017332009 cites W2087939913 @default.
• W2017332009 cites W2092975931 @default.
• W2017332009 cites W2094919697 @default.
• W2017332009 cites W2107235439 @default.
• W2017332009 cites W2109879635 @default.
• W2017332009 cites W2110910354 @default.
• W2017332009 cites W2112866067 @default.
• W2017332009 cites W2124376257 @default.
• W2017332009 cites W2134728320 @default.
• W2017332009 cites W2150926065 @default.
• W2017332009 cites W2151109138 @default.
• W2017332009 cites W2155779547 @default.
• W2017332009 cites W2156564635 @default.
• W2017332009 cites W2161681716 @default.
• W2017332009 cites W2162162619 @default.
• W2017332009 cites W2171321889 @default.
• W2017332009 cites W2776663677 @default.
• W2017332009 cites W4313343514 @default.
• W2017332009 doi "https://doi.org/10.1038/nm.2110" @default.
• W2017332009 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3042885" @default.
• W2017332009 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20348925" @default.
• W2017332009 hasPublicationYear "2010" @default.
• W2017332009 type Work @default.
• W2017332009 sameAs 2017332009 @default.
• W2017332009 citedByCount "503" @default.
• W2017332009 countsByYear W20173320092012 @default.
• W2017332009 countsByYear W20173320092013 @default.
• W2017332009 countsByYear W20173320092014 @default.
• W2017332009 countsByYear W20173320092015 @default.
• W2017332009 countsByYear W20173320092016 @default.
• W2017332009 countsByYear W20173320092017 @default.
• W2017332009 countsByYear W20173320092018 @default.
• W2017332009 countsByYear W20173320092019 @default.
• W2017332009 countsByYear W20173320092020 @default.
• W2017332009 countsByYear W20173320092021 @default.
• W2017332009 countsByYear W20173320092022 @default.
• W2017332009 countsByYear W20173320092023 @default.
• W2017332009 crossrefType "journal-article" @default.
• W2017332009 hasAuthorship W2017332009A5000641039 @default.
• W2017332009 hasAuthorship W2017332009A5013627205 @default.
• W2017332009 hasAuthorship W2017332009A5020603727 @default.
• W2017332009 hasAuthorship W2017332009A5021321096 @default.
• W2017332009 hasAuthorship W2017332009A5021775232 @default.
• W2017332009 hasAuthorship W2017332009A5031900866 @default.
• W2017332009 hasAuthorship W2017332009A5032730610 @default.
• W2017332009 hasAuthorship W2017332009A5037905104 @default.
• W2017332009 hasAuthorship W2017332009A5041768709 @default.
• W2017332009 hasAuthorship W2017332009A5044949501 @default.
• W2017332009 hasAuthorship W2017332009A5049519284 @default.
• W2017332009 hasAuthorship W2017332009A5056838229 @default.
• W2017332009 hasAuthorship W2017332009A5065640717 @default.
• W2017332009 hasAuthorship W2017332009A5074815989 @default.
• W2017332009 hasAuthorship W2017332009A5076669758 @default.
• W2017332009 hasAuthorship W2017332009A5078507054 @default.
• W2017332009 hasAuthorship W2017332009A5080425769 @default.
• W2017332009 hasAuthorship W2017332009A5083119149 @default.
• W2017332009 hasAuthorship W2017332009A5091865567 @default.

• next